Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund
Singapore
LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.
European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.
TRENDING NOW
Malaysian king buys stake in Singapore-listed mining firm expanding into rare earths
Family offices ‘kept captive’ by relationship managers turn to independent advisers, direct deals
Once staunchly pro-China, Malaysian Chinese businesses are now distancing themselves from Beijing
Could stablecoins be the future of money?